General Surgery Department, Carle Foundation Hospital, Urbana, Illinois, USA.
University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Breast J. 2020 Oct;26(10):1960-1965. doi: 10.1111/tbj.14057. Epub 2020 Oct 19.
Systematic cavity shave margins (CSM) can decrease rate of positive margins and re-excision beyond that of selective CSM. The objective of this study was to determine whether systematic CSM decreased re-excision rate in a population with a low baseline re-excision rate. We conducted a retrospective chart review of patients who underwent breast-conserving surgery (BCS) from November 2013 to November 2017. Primary end points were re-excision rate and margin status. Secondary end points were total volume of tissue excised, operative time, and concordance of core needle biopsy (CNB) pathology with final surgical pathology. The re-excision rates were 14.29% in the no shave margin group; 15.38% in the selective CSM; and 14.59% in the systematic CSM (P = .985). Odds of re-excision with ductal carcinoma in situ (DCIS) was 5.04 times greater than with invasive cancer (INV) and 1.94 times higher than with INV and DCIS. There was no significant difference in positive margins between groups (P = .362). Mean specimen volume was lowest in the systematic CSM group (64.6 cm ), compared to no CSM and selective CSM (94.6 cm and 91.8 cm , respectively). With inclusion of shave margin volumes, total volume removed was not significantly different between no shave margin group (94.6 cm ) and systematic CSM (89.7 cm ) (P = .949). For patients with invasive ductal carcinoma (IDC) alone on their initial biopsy pathology, 69% were discovered to also have DCIS upon final pathology. Re-excision rate and specimen volume between all groups were not statistically different. There was a higher re-excision rate when DCIS was present, especially when not identified on CNB. As systematic CSM is most impactful when DCIS is involved, it is important to establish its presence for proper surgical planning.
系统腔隙刮除边缘(CSM)可以降低阳性边缘的发生率和选择性 CSM 以外的再次切除率。本研究的目的是确定在基线再次切除率较低的人群中,系统 CSM 是否会降低再次切除率。我们对 2013 年 11 月至 2017 年 11 月接受保乳手术(BCS)的患者进行了回顾性图表审查。主要终点是再次切除率和边缘状态。次要终点是切除组织的总体积、手术时间以及核心针活检(CNB)病理与最终手术病理的一致性。无 shave 边缘组的再次切除率为 14.29%;选择性 CSM 组为 15.38%;系统 CSM 组为 14.59%(P=.985)。导管原位癌(DCIS)的再次切除几率是浸润性癌(INV)的 5.04 倍,比 INV 和 DCIS 的总和高 1.94 倍。各组之间的阳性边缘无显著差异(P=.362)。在系统 CSM 组中,标本体积最小(64.6cm),与无 CSM 组和选择性 CSM 组(分别为 94.6cm 和 91.8cm)相比。包括 shave 边缘体积在内,无 shave 边缘组(94.6cm)和系统 CSM 组(89.7cm)之间的总切除体积无显著差异(P=.949)。对于初始活检病理仅为浸润性导管癌(IDC)的患者,69%的患者最终病理发现同时存在 DCIS。所有组之间的再次切除率和标本体积均无统计学差异。当存在 DCIS 时,再次切除率较高,尤其是在 CNB 未识别时。由于系统 CSM 对 DCIS 的影响最大,因此对于适当的手术计划,确定其存在非常重要。